Project Details
Description
A Phase 1/2, open-label, dose escalation study to evaluate the safety and efficacy of mRNA-3704 in patients with isolated methylmalonic acidemia (MMA) due to MUT deficiency
| Status | Finished |
|---|---|
| Effective start/end date | 2/1/20 → 9/10/21 |
Funding
- MODERNATX, INC.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.